REGENERON PHARMACEUTICALS, INC. R&D Expense 2008-2025 | REGN
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is REGENERON PHARMACEUTICALS, INC.'s current r&d expense?
REGENERON PHARMACEUTICALS, INC. (REGN) annual r&d expense for 2025 was $5.85B, a 13.99% increase from 2024. REGENERON PHARMACEUTICALS, INC. r&d expense for the quarter ending December 31, 2025 was $1.63B.
What was REGENERON PHARMACEUTICALS, INC.'s r&d expense in 2024?
REGENERON PHARMACEUTICALS, INC. annual r&d expense for 2024 was $5.13B, a 15.61% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s r&d expense in 2023?
REGENERON PHARMACEUTICALS, INC. annual r&d expense for 2023 was $4.44B, a 23.56% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year r&d expense CAGR?
REGENERON PHARMACEUTICALS, INC. r&d expense grew at a compound annual growth rate (CAGR) of 17.19% from FY2020 to FY2025, going from $2.65B to $5.85B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $5.85B | +14.0% | 10-K |
| FY2024 | $5.13B | +15.6% | 10-K |
| FY2023 | $4.44B | +23.6% | 10-K |
| FY2022 | $3.59B | +25.6% | 10-K |
| FY2021 | $2.86B | +8.1% | 10-K |
| FY2020 | $2.65B | +8.0% | 10-K |
| FY2019 | $2.45B | +66.8% | 10-K |
| FY2018 | $1.47B | -29.2% | 10-K |
| FY2017 | $2.08B | +1.1% | 10-K |
| FY2016 | $2.05B | +26.6% | 10-K |
| FY2015 | $1.62B | +27.5% | 10-K |
| FY2014 | $1.27B | +47.8% | 10-K |
| FY2013 | $859.9M | +37.5% | 10-K |
| FY2012 | $625.6M | +18.1% | 10-K |
| FY2011 | $529.5M | +8.2% | 10-K |
| FY2010 | $489.3M | +22.7% | 10-K |
| FY2009 | $398.8M | +45.1% | 10-K |
| FY2008 | $274.9M | - | 10-K |